• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用过突变和低突变基因对TCGA数据进行进化分析,以识别肺癌亚型中的关键分子途径和细胞功能。

Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes.

作者信息

Freischel Audrey R, Teer Jamie K, Luddy Kimberly, Cunningham Jessica, Artzy-Randrup Yael, Epstein Tamir, Tsai Kenneth Y, Berglund Anders, Cleveland John L, Gillies Robert J, Brown Joel S, Gatenby Robert A

机构信息

Departments of Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.

Cancer Biology and Evolution Program, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.

出版信息

Cancers (Basel). 2022 Dec 20;15(1):18. doi: 10.3390/cancers15010018.

DOI:10.3390/cancers15010018
PMID:36612014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9817988/
Abstract

We identify critical conserved and mutated genes through a theoretical model linking a gene’s fitness contribution to its observed mutational frequency in a clinical cohort. “Passenger” gene mutations do not alter fitness and have mutational frequencies determined by gene size and the mutation rate. Driver mutations, which increase fitness (and proliferation), are observed more frequently than expected. Non-synonymous mutations in essential genes reduce fitness and are eliminated by natural selection resulting in lower prevalence than expected. We apply this “evolutionary triage” principle to TCGA data from EGFR-mutant, KRAS-mutant, and NEK (non-EGFR/KRAS) lung adenocarcinomas. We find frequent overlap of evolutionarily selected non-synonymous gene mutations among the subtypes suggesting enrichment for adaptations to common local tissue selection forces. Overlap of conserved genes in the LUAD subtypes is rare suggesting negative evolutionary selection is strongly dependent on initiating mutational events during carcinogenesis. Highly expressed genes are more likely to be conserved and significant changes in expression (>20% increased/decreased) are common in genes with evolutionarily selected mutations but not in conserved genes. EGFR-mut cancers have fewer average mutations (89) than KRAS-mut (228) and NEK (313). Subtype-specific variation in conserved and mutated genes identify critical molecular components in cell signaling, extracellular matrix remodeling, and membrane transporters. These findings demonstrate subtype-specific patterns of co-adaptations between the defining driver mutation and somatically conserved genes as well as novel insights into epigenetic versus genetic contributions to cancer evolution.

摘要

我们通过一个理论模型来识别关键的保守基因和突变基因,该模型将基因的适应性贡献与其在临床队列中观察到的突变频率联系起来。“乘客”基因突变不会改变适应性,其突变频率由基因大小和突变率决定。驱动突变会增加适应性(以及增殖能力),其观察到的频率高于预期。必需基因中的非同义突变会降低适应性,并通过自然选择被淘汰,导致其患病率低于预期。我们将这种“进化筛选”原则应用于来自表皮生长因子受体(EGFR)突变型、 Kirsten 大鼠肉瘤病毒癌基因(KRAS)突变型和NEK(非EGFR/KRAS)肺腺癌的癌症基因组图谱(TCGA)数据。我们发现各亚型之间进化选择的非同义基因突变经常重叠,这表明存在对共同局部组织选择压力的适应性富集。肺腺癌亚型中保守基因的重叠很少见,这表明负向进化选择强烈依赖于致癌过程中的起始突变事件。高表达基因更有可能是保守的,并且在具有进化选择突变的基因中,表达的显著变化(增加/减少>20%)很常见,但在保守基因中则不然。EGFR突变型癌症的平均突变数(89个)比KRAS突变型(228个)和NEK(313个)少。保守基因和突变基因的亚型特异性变异确定了细胞信号传导、细胞外基质重塑和膜转运蛋白中的关键分子成分。这些发现揭示了定义驱动突变与体细胞保守基因之间共同适应的亚型特异性模式,以及对癌症进化中表观遗传与遗传贡献的新见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a5c/9817988/045793610b23/cancers-15-00018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a5c/9817988/33eb8a8eab40/cancers-15-00018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a5c/9817988/045793610b23/cancers-15-00018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a5c/9817988/33eb8a8eab40/cancers-15-00018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a5c/9817988/045793610b23/cancers-15-00018-g002.jpg

相似文献

1
Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes.使用过突变和低突变基因对TCGA数据进行进化分析,以识别肺癌亚型中的关键分子途径和细胞功能。
Cancers (Basel). 2022 Dec 20;15(1):18. doi: 10.3390/cancers15010018.
2
Lung adenocarcinomas without driver genes converge to common adaptive strategies through diverse genetic, epigenetic, and niche construction evolutionary pathways.无驱动基因的肺腺癌通过不同的遗传、表观遗传和小生境构建进化途径汇聚到共同的适应性策略。
Med Oncol. 2024 May 5;41(6):135. doi: 10.1007/s12032-024-02344-2.
3
Evolutionary selection identifies critical immune-relevant genes in lung cancer subtypes.进化选择确定了肺癌亚型中与免疫相关的关键基因。
Front Genet. 2022 Aug 24;13:921447. doi: 10.3389/fgene.2022.921447. eCollection 2022.
4
Molecular Signatures of -Mutated Lung Adenocarcinoma: Analysis of Concomitant , , , and PD-L1 Status.KRAS 突变型肺腺癌的分子特征:伴发的 EGFR、ALK、BRAF 及 PD-L1 状态分析
Clin Pathol. 2022 May 23;15:2632010X221102054. doi: 10.1177/2632010X221102054. eCollection 2022 Jan-Dec.
5
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways.非小细胞肺癌中的 K-ras 基因突变亚型及其他致癌通路中的相关共发生突变。
J Thorac Oncol. 2019 Apr;14(4):606-616. doi: 10.1016/j.jtho.2018.12.013. Epub 2018 Dec 31.
6
Genomic landscape and prognosis of patients with -mutated non-small cell lung cancer.具有特定突变的非小细胞肺癌患者的基因组格局与预后
Ann Transl Med. 2022 Feb;10(4):188. doi: 10.21037/atm-22-412.
7
Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.通过多区域组织和配对 ctDNA 测序比较非小细胞肺癌不同亚型的肿瘤内异质性。
Mol Cancer. 2019 Jan 9;18(1):7. doi: 10.1186/s12943-019-0939-9.
8
EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.韩国非小细胞肺癌患者的表皮生长因子受体(EGFR)、人表皮生长因子受体2(ERBB2)和 Kirsten 大鼠肉瘤病毒癌基因(KRAS)突变
Cancer Genet Cytogenet. 2007 Mar;173(2):107-13. doi: 10.1016/j.cancergencyto.2006.10.007.
9
Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma.通过对手术切除的肺腺癌进行全面分析,确定了浸润前和浸润性亚型之间的独特突变特征。
Mod Pathol. 2022 Sep;35(9):1181-1192. doi: 10.1038/s41379-022-01076-w. Epub 2022 May 31.
10
The co-mutation of and tumor-related genes leads to a worse prognosis and a higher level of tumor mutational burden in Chinese non-small cell lung cancer patients.在中国非小细胞肺癌患者中,[具体基因]与肿瘤相关基因的共同突变导致预后更差以及肿瘤突变负荷水平更高。 (原文中“and”前面缺少具体基因信息)
J Thorac Dis. 2022 Jan;14(1):185-193. doi: 10.21037/jtd-21-1921.

引用本文的文献

1
Limited survival benefit in patients diagnosed with glioblastoma post-2016: a SEER population based registry analysis.2016年后诊断为胶质母细胞瘤患者的生存获益有限:一项基于监测、流行病学和最终结果(SEER)数据库人群的登记分析
J Cancer Res Clin Oncol. 2025 Jun 2;151(6):179. doi: 10.1007/s00432-025-06171-4.
2
Survival prediction in glioblastoma: 10-year follow-up from the Dutch Neurosurgery Quality Registry.胶质母细胞瘤的生存预测:来自荷兰神经外科质量登记处的10年随访
J Neurooncol. 2025 May 23. doi: 10.1007/s11060-025-05080-3.
3
Parallel and convergent dynamics in the evolution of primary breast and lung adenocarcinomas.

本文引用的文献

1
Mutation bias reflects natural selection in Arabidopsis thaliana.突变偏向反映了拟南芥中的自然选择。
Nature. 2022 Feb;602(7895):101-105. doi: 10.1038/s41586-021-04269-6. Epub 2022 Jan 12.
2
Premetastatic shifts of endogenous and exogenous mutational processes support consolidative therapy in EGFR-driven lung adenocarcinoma.内源性和外源性突变过程的前转移变化支持 EGFR 驱动的肺腺癌的巩固性治疗。
Cancer Lett. 2022 Feb 1;526:346-351. doi: 10.1016/j.canlet.2021.11.011. Epub 2021 Nov 12.
3
Every gene can (and possibly will) be associated with cancer.
原发性乳腺癌和肺癌进化中的平行与趋同动态
Commun Biol. 2025 May 21;8(1):775. doi: 10.1038/s42003-025-08123-7.
4
Imply on diagnosis and early prognosis of preoperative [Ga]Ga-PSMA-11 PET/CT in patients with suspected brain tumours of glial origin.术前[镓]镓-PSMA-11 PET/CT对疑似胶质源性脑肿瘤患者的诊断及早期预后的意义。
Sci Rep. 2025 Jan 2;15(1):214. doi: 10.1038/s41598-024-84036-5.
5
Lung adenocarcinomas without driver genes converge to common adaptive strategies through diverse genetic, epigenetic, and niche construction evolutionary pathways.无驱动基因的肺腺癌通过不同的遗传、表观遗传和小生境构建进化途径汇聚到共同的适应性策略。
Med Oncol. 2024 May 5;41(6):135. doi: 10.1007/s12032-024-02344-2.
6
Evolutionary selection identifies critical immune-relevant genes in lung cancer subtypes.进化选择确定了肺癌亚型中与免疫相关的关键基因。
Front Genet. 2022 Aug 24;13:921447. doi: 10.3389/fgene.2022.921447. eCollection 2022.
每个基因都可能(并且有可能)与癌症有关。
Trends Genet. 2022 Mar;38(3):216-217. doi: 10.1016/j.tig.2021.09.005. Epub 2021 Oct 27.
4
Integrative analyses identified ion channel genes GJB2 and SCNN1B as prognostic biomarkers and therapeutic targets for lung adenocarcinoma.整合分析鉴定出离子通道基因 GJB2 和 SCNN1B 可作为肺腺癌的预后生物标志物和治疗靶点。
Lung Cancer. 2021 Aug;158:29-39. doi: 10.1016/j.lungcan.2021.06.001. Epub 2021 Jun 6.
5
VPS13D promotes peroxisome biogenesis.VPS13D 促进过氧化物酶体的生物发生。
J Cell Biol. 2021 May 3;220(5). doi: 10.1083/jcb.202001188.
6
Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer.吸烟史与晚期非小细胞肺癌肿瘤突变负荷的相关性。
Cancer Res. 2021 May 1;81(9):2566-2573. doi: 10.1158/0008-5472.CAN-20-3991. Epub 2021 Mar 2.
7
Using The Cancer Genome Atlas as an Inquiry Tool in the Undergraduate Classroom.将癌症基因组图谱用作本科课堂的探究工具。
Front Genet. 2020 Dec 16;11:573992. doi: 10.3389/fgene.2020.573992. eCollection 2020.
8
Gain-of-function mutant p53 in cancer progression and therapy.抑癌基因 p53 功能获得性突变与癌症的发生发展及治疗
J Mol Cell Biol. 2020 Sep 1;12(9):674-687. doi: 10.1093/jmcb/mjaa040.
9
CTCF and CTCFL in cancer.CTCF 和 CTCFL 在癌症中的作用。
Curr Opin Genet Dev. 2020 Apr;61:44-52. doi: 10.1016/j.gde.2020.02.021. Epub 2020 Apr 22.
10
A negative storage model for precise but compact storage of genetic variation data.一种用于精确且紧凑存储遗传变异数据的负存储模型。
Database (Oxford). 2020 Jan 1;2020. doi: 10.1093/database/baz158.